As immune-mediated tumor rejection becomes more pronounced (higher ICR immune subtype), it appears that effector T cells are found at greater distances from CD3+FoxP3+ T cells, which mainly perform immune regulatory function in this context. The gene discussed is FOXP3; the disease is neoplasm.